JP2013528577A5 - - Google Patents

Download PDF

Info

Publication number
JP2013528577A5
JP2013528577A5 JP2013506566A JP2013506566A JP2013528577A5 JP 2013528577 A5 JP2013528577 A5 JP 2013528577A5 JP 2013506566 A JP2013506566 A JP 2013506566A JP 2013506566 A JP2013506566 A JP 2013506566A JP 2013528577 A5 JP2013528577 A5 JP 2013528577A5
Authority
JP
Japan
Prior art keywords
water
fluorobenzyloxy
benzylamino
crystallization
propanamide methanesulfonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013506566A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013528577A (ja
JP5808392B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/055309 external-priority patent/WO2011134763A1/en
Publication of JP2013528577A publication Critical patent/JP2013528577A/ja
Publication of JP2013528577A5 publication Critical patent/JP2013528577A5/ja
Application granted granted Critical
Publication of JP5808392B2 publication Critical patent/JP5808392B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013506566A 2010-04-27 2011-04-06 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法 Active JP5808392B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10161207 2010-04-27
EP10161207.5 2010-04-27
PCT/EP2011/055309 WO2011134763A1 (en) 2010-04-27 2011-04-06 Process for the production of ralfinamide methanesulfonate salts or their r-enantiomers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015104930A Division JP6345154B2 (ja) 2010-04-27 2015-05-22 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法

Publications (3)

Publication Number Publication Date
JP2013528577A JP2013528577A (ja) 2013-07-11
JP2013528577A5 true JP2013528577A5 (https=) 2015-03-05
JP5808392B2 JP5808392B2 (ja) 2015-11-10

Family

ID=42634917

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013506566A Active JP5808392B2 (ja) 2010-04-27 2011-04-06 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法
JP2015104930A Active JP6345154B2 (ja) 2010-04-27 2015-05-22 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法
JP2017106571A Active JP6450420B2 (ja) 2010-04-27 2017-05-30 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015104930A Active JP6345154B2 (ja) 2010-04-27 2015-05-22 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法
JP2017106571A Active JP6450420B2 (ja) 2010-04-27 2017-05-30 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法

Country Status (27)

Country Link
US (2) US9505708B2 (https=)
EP (1) EP2563355B1 (https=)
JP (3) JP5808392B2 (https=)
KR (1) KR101851118B1 (https=)
CN (2) CN102858330B (https=)
AR (1) AR085171A1 (https=)
AU (1) AU2011246707B2 (https=)
BR (1) BR112012027623B1 (https=)
CA (1) CA2794389C (https=)
CY (1) CY1117879T1 (https=)
DK (1) DK2563355T3 (https=)
EA (1) EA021389B1 (https=)
ES (1) ES2590128T3 (https=)
HR (1) HRP20161077T1 (https=)
HU (1) HUE030504T2 (https=)
IL (1) IL222532A (https=)
LT (1) LT2563355T (https=)
ME (1) ME02509B (https=)
MX (1) MX342697B (https=)
NZ (2) NZ602648A (https=)
PL (1) PL2563355T3 (https=)
PT (1) PT2563355T (https=)
RS (1) RS55084B1 (https=)
SI (1) SI2563355T1 (https=)
SM (1) SMT201600266B (https=)
TW (1) TWI492919B (https=)
WO (1) WO2011134763A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5808392B2 (ja) * 2010-04-27 2015-11-10 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法
CN103804341B (zh) * 2012-11-13 2018-04-10 中国人民解放军军事医学科学院毒物药物研究所 酰胺衍生物及其医药用途
CN104761531B (zh) * 2014-01-03 2017-12-01 中国人民解放军军事医学科学院毒物药物研究所 镇痛活性化合物及其医药用途
CN104292128A (zh) * 2014-07-01 2015-01-21 南京正科制药有限公司 一种沙芬酰胺晶型a
CN115368310B (zh) * 2021-05-18 2025-06-27 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94466A (en) 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
GB9515412D0 (en) * 1995-07-27 1995-09-27 Pharmacia Spa 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
IL160523A0 (en) 2001-09-03 2004-07-25 Newron Pharm Spa PHARMACEUTICAL COMPOSITION COMPRISING GABAPENTIN OR AN ANALOGUE THEREOF AND AN alpha-AMINOAMIDE AND ITS ANALGESIC USE
EP1438956A1 (en) 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
US20040213842A1 (en) * 2003-01-30 2004-10-28 Dynogen Pharmaceuticals, Inc. Methods of treating gastrointestinal tract disorders using sodium channel modulators
AR044007A1 (es) 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
AU2004266494B2 (en) 2003-08-25 2010-04-08 Newron Pharmaceuticals, Spa Alpha-aminoamide derivatives useful as anti-inflammatory agents
EP1557166A1 (en) 2004-01-21 2005-07-27 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
EP1588704A1 (en) 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
ATE471147T1 (de) * 2004-09-10 2010-07-15 Newron Pharm Spa Verwendung von (r)-(halogenbenzyloxy)-benzylamino-propanamiden als natrium- und/oder calciumkanal- selektive modulatoren
EP1870097A1 (en) 2006-06-15 2007-12-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
HUE030233T2 (en) * 2006-06-19 2017-04-28 Newron Pharm Spa High purity 2- [4- (3- and 2-fluorobenzyloxy) benzylamino] propanamides for use as medicaments and pharmaceutical compositions containing them
JP5315674B2 (ja) * 2007-11-19 2013-10-16 セントラル硝子株式会社 非水電池用電解液及びこれを用いた非水電池
CA2936209C (en) * 2007-12-11 2020-02-11 Newron Pharmaceuticals S.P.A. Process for the production of 2-[4-(3- or 2-fluorobenzyloxy)benzylamino]propanamides with high purity degree
BRPI0821026A2 (pt) 2007-12-19 2015-06-16 Newron Pharmaceutical S P A Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos
WO2009109334A1 (en) 2008-03-07 2009-09-11 Newron Pharmaceuticals S.P.A. (s)-(+)-2-[4-fluorbenzyloxy)benzylamino]propanamide for use in the treatment of mixed or combined pain
JP5808392B2 (ja) * 2010-04-27 2015-11-10 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法

Similar Documents

Publication Publication Date Title
JP2011126894A5 (https=)
JP2013528577A5 (https=)
EA201490616A1 (ru) Использование ацилсульфонамидов для улучшения урожайности растений
JP2012528877A5 (https=)
WO2012004396A3 (en) Process of preparing a thrombin specific inhibitor
NO20091301L (no) Nye aminopyridinderivater med aurora A selektiv inhiberende aktivitet
PH12022552034A1 (en) Pyridone derivative having tetrahydropyranyl methyl group
JP2013542935A5 (https=)
RU2016151420A (ru) Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий
WO2012031045A3 (en) Phosphonate ester derivatives and methods of synthesis thereof
ME02054B (me) Agomelatin hidroklorid hidrat i njegova priprava
MX363405B (es) Derivados de indanona, sales farmaceuticamente aceptables o isomeros opticos de los mismos, metodo de preparacion de los mismos, y composiciones farmaceuticas que contienen los mismos como ingrediente activo para prevención o tratamiento de enfermedades virales.
MD4415B1 (ro) Procedeu de preparare a formei cristaline delta a sării perindopril-L-arginină
AR081267A1 (es) Procedimiento de obtencion de la forma cristalina a del febuxostat
ME02309B (me) Agomelatin hidrobromid hidrat i njegova priprema
JP2011529942A5 (https=)
MY161463A (en) Process for the preparation of substantially pure methylthionium chloride pentahydrate form a
JP4967659B2 (ja) L−カルニチンの精製方法
WO2013172741A3 (ru) Фторзамещенные (3r,4r,5s)-5-гуанидино-4-ациламино-3-(пентан-3-илокси) циклогексен-1-карбоновые кислоты, их эфиры и способ применения
NZ700221A (en) Ralfinamide methanesulfonate salts
MX355498B (es) Derivados de 1,3-dioxoindeno, sal farmaceuticamente aceptable de los mismos, metodos de preparacion de los mismos y composicion farmaceutica para el antivirus que contiene el mismo como un ingrediente activo.
RU2011143166A (ru) Новые кристаллические формы адефовира дипивоксила и способы его получения
RU2013122374A (ru) Препарат, обладающий антитоксической активностью и содержащий комплексное соединение производного метилурацила с органической кислотой, и способ его получения
WO2015000555A3 (en) A novel process for the preparation of tetralin and naphthalene derivatives
WO2012134102A3 (ko) 노보넨 디에스터 유도체, 이의 제조방법 및 이의 용도